Literature DB >> 7651974

Synthesis and investigation of N4-substituted cytarabine derivatives as prodrugs.

T A Fadl1, T Hasegawa, A F Youssef, H H Farag, F A Omar, T Kawaguchi.   

Abstract

Esters of Cytarabine-N4-carboxylates 2a-i and succinamates 3a-f were synthesized as prodrugs of cytarabine (Ara-C) with the aim of developing improved derivatives for oral or parentral administration. At pH 2 series 2 showed relative higher stability than 3, while both series of esters revealed matched stability at pH 7. All esters were susceptible to enzymatic hydrolysis by rat plasma and liver homogenate with half lives ranged from 0.14 h to 12 d, and showed improved stability against cytidine deaminase. A parabolic relation was shown between Kobs of enzymatic hydrolysis and Vw. All compounds are more lipophilic than the parent drug, Ara-C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651974

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies.

Authors:  Jill Gilbert; Michael A Carducci; Sharyn D Baker; Elizabeth C Dees; Ross Donehower
Journal:  Invest New Drugs       Date:  2006-11       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.